OPP002 📄 Overview A prescribed digital therapeutic (DTx) platform offering personalized cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) based interventions for conditions like anxiety, depression, or chronic stress. It combines adaptive AI-driven content and exercises with passive biometric monitoring from wearables (e.g., heart rate variability, sleep patterns) to track progress, predict potential relapses, and provide real-time, context-aware support. Includes a secure communication channel for intermittent therapist support. Key technologies: 👤 Target users: 👍 Benefits Scalable and accessible mental healthcare solutions • Improved symptom management and long-term wellbeing • Reduced burden on traditional mental health services • Enhanced patient self-efficacy and coping skills Use bullets or new lines. 👎 Challenges Ensuring clinical efficacy through rigorous trials • Sustaining long-term patient engagement and adherence • Ethical considerations around AI in therapy and data privacy • Integration with existing mental health provider networks and reimbursement pathways 📋 Regulatory & Validation Typically Class II SaMD, requiring FDA clearance (or equivalent) as a DTx based on clinical claims. • Stringent requirements for data privacy, security, and algorithmic transparency. • Clinical evidence from randomized controlled trials is essential.